The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Neuropsychiatric Systemic Lupus Erythematosus: Diagnosis and Management

Recognition and treatment of central and peripheral nervous system manifestations of systemic lupus erythematosus across diverse psychiatric and neurological syndromes

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Psikiyatri department. Book Appointment →

What is Neuropsychiatric Systemic Lupus Erythematosus: Diagnosis and Management?

NPSLE encompasses 19 ACR-defined neuropsychiatric syndromes affecting central and peripheral nervous systems.

Pathophysiology involves autoantibody-mediated injury, thrombotic events, vasculopathy and cytokine-mediated mechanisms.

NPSLE affects 30-40% of lupus patients with diverse presentations from subtle cognitive dysfunction to severe psychosis.

Diagnosis requires attribution to lupus excluding alternative causes including infection, metabolic, drug-induced and primary psychiatric.

Pathophysiologic mechanism guides treatment with immunosuppression for inflammatory and anticoagulation for thrombotic.

Symptoms

Cognitive dysfunction with attention, memory, executive function impairment is most common manifestation.
Psychosis with hallucinations, delusions and disorganized thinking warrants urgent evaluation.
Mood disorders including depression and anxiety occur in significant proportion of patients.
Seizures, stroke, transient ischemic attacks, headaches, movement disorders manifest neurologic involvement.
Peripheral neuropathy, mononeuritis multiplex, autonomic dysfunction represent peripheral manifestations.

Risk Factors

Active systemic lupus disease activity correlates with higher risk of NPSLE manifestations.
Antiphospholipid antibody positivity strongly predicts thrombotic NPSLE manifestations including stroke.
Anti-ribosomal P antibodies associate with lupus psychosis and depression.
Anti-NMDA receptor antibodies associate with cognitive dysfunction and mood disorders.
Concurrent corticosteroid therapy may contribute to mood and psychotic symptoms requiring careful attribution.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Lupus patient with new neuropsychiatric symptoms warrants urgent evaluation for NPSLE.
  • Acute psychosis, seizures, stroke symptoms in lupus patient require emergency evaluation and treatment.
  • Multidisciplinary care with rheumatology, neurology, psychiatry, neuropsychology essential.
  • Comprehensive workup including brain MRI, lumbar puncture, antibody profile, neuropsychological testing guides diagnosis.
  • Distinguishing NPSLE from infection, drug toxicity, metabolic disturbance critical for appropriate treatment.

Treatment Methods

01
Immunosuppressive therapy with high-dose corticosteroids, cyclophosphamide or rituximab for inflammatory NPSLE.
02
Anticoagulation with warfarin for antiphospholipid-mediated thrombotic NPSLE manifestations.
03
Antiepileptic medications, antipsychotics, antidepressants for symptomatic management.
04
Mycophenolate mofetil maintenance therapy for lupus disease activity.
05
Comprehensive multidisciplinary care with rheumatology, neurology, psychiatry, neuropsychology coordination, hydroxychloroquine for all lupus patients, blood pressure and cardiovascular risk management, neurorehabilitation for stroke or cognitive impairment, mental health support, monitoring for relapses, careful corticosteroid management balancing efficacy with neuropsychiatric side effects, antiphospholipid antibody monitoring and thromboprophylaxis, pregnancy planning for women with childbearing potential, and long-term follow-up addressing damage accrual provides optimal outcomes for patients with neuropsychiatric systemic lupus erythematosus.

Which Department to Visit?

You can visit our Psikiyatri department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Psikiyatri Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.